Biểu đồ giá cổ phiếu ACIU
ACIU Dự đoán giá cổ phiếu
AC Immune SA
$2.56
1.58%
$0.04
Tính đến ngày hôm nay:Jul 09, 12:40:16 GMT-4
Quay lại
AC Immune SA (ACIU) Dự đoán giá cổ phiếu
Thống kê chính
Giá đóng cửa trước
$2.52
Giá mở cửa
$2.51
Phạm vi ngày
$2.5 - $2.6
Phạm vi 52 tuần
$1.65 - $4
Khối lượng
103.5K
Khối lượng trung bình
285.1K
Tỷ suất cổ tức
--
EPS (TTM)
-0.66
Vốn hóa thị trường
$260.5M
ACIU là gì?
AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. The firm focuses on precision medicine for neurodegenerative diseases. The company designs, discovers and develops therapeutic, as well as diagnostic products for prevention, diagnosis and treatment of diseases caused by misfolding proteins. Its SupraAntigen and Morphomer technology platforms to create antibodies, small molecules and vaccines designed to address a broad range of neurodegenerative indications, such as Alzheimer's disease (AD). The firm's pipeline includes nine therapeutic product candidates with five in clinical trials, and three diagnostic candidates. Its lead product candidate is Crenezumab, a humanized and monoclonal anti-Abeta antibody for Alzheimer’s disease. The company has collaborations with pharmaceutical companies, including Roche/Genentech, Eli Lilly, Biogen, Janssen Pharmaceuticals, Nestle Institute of Health Sciences, Life Molecular Imaging (formerly Piramal Imaging) and Essex Bio-Technology.
